ArticleScientific reports2023

CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis.

Tamir Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.